"Svitavská nemocnice je součástí společnosti Nemocnice Pardubického kraje, a. s. Ta se s ročním obratem více než 3,5 miliardy korun a zhruba 4 600 zaměstnanci řadí mezi desítku největších nemocnic v zemi. Společnost tvoří pět pracovišť: • Pardubická nemocnice • Chrudimská nemocnice • Orlickoústecká nemocnice • Litomyšlská nemocnice • Svitavská nemocnice"

During the past decade, Nemocnice Pardubickeho kraje, a.s., Svitavska nemocnice conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nemocnice Pardubickeho kraje, a.s., Svitavska nemocnice" are "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Nemocnice Pardubickeho kraje, a.s., Svitavska nemocnice" in a lesser frequency.

Most popular intervention types in "Nemocnice Pardubickeho kraje, a.s., Svitavska nemocnice" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnice Pardubickeho kraje, a.s., Svitavska nemocnice" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Nemocnice Pardubickeho kraje, a.s., Svitavska nemocnice". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Nemocnice Pardubickeho kraje, a.s., Svitavska nemocnice, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnice Pardubickeho kraje, a.s., Svitavska nemocnice, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".